4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-006501
Options or other derivatives
- Senior VP - Drug Discovery acquired 31,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Babu Yarlagadda S · Senior VP - Drug Discovery
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-14 | Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) | +31,500 | 31,500 | D |
Loading xslF345X03/form4.xml…